used fluorescence-activated cell sorting to isolated CD45-CD235a-AP-CD34-EpCAM+ DTCs and found in 17% of PCa patients (10 out of 58) with local and in 50% with metastatic disease (4 out of 8) >5 DTCs per 106 bone cells. The gene discussed is EPCAM; the disease is posterior cortical atrophy.